Cargando…

Reticulocalbin3: A Ca(2+) homeostasis regulator that promotes esophageal squamous cell carcinoma progression and cisplatin resistance

Esophageal squamous cell carcinoma (ESCC) is one of the most prevalent cancers worldwide. There is a critical need to identify new mechanisms that contribute to ESCC progression. Reticulocalbin3 (RCN3) is mainly located in the endoplasmic reticulum and Ca(2+)‐binding protein containing EF‐hands. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Rui, Wang, Ping, Zhao, Xin, Lu, Xiansheng, Deng, Ruxia, Wang, Xiaoyu, Hong, Chang, Lin, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530876/ https://www.ncbi.nlm.nih.gov/pubmed/35839283 http://dx.doi.org/10.1111/cas.15487

Ejemplares similares

LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation
por: Cai, Rui, et al.
Publicado: (2020)

Reticulocalbin-1 Facilitates Microglial Phagocytosis
por: Ding, Ying, et al.
Publicado: (2015)

Reticulocalbin 3 Is a Novel Mediator of Glioblastoma Progression
por: He, Yi, et al.
Publicado: (2023)

Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis
por: Deng, Ruxia, et al.
Publicado: (2022)

Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis
por: Li, Jing, et al.
Publicado: (2022)

Downregulation of reticulocalbin‐1 differentially facilitates apoptosis and necroptosis in human prostate cancer cells
por: Liu, Xiaofei, et al.
Publicado: (2018)

Reticulocalbin 3 is involved in postnatal tendon development by regulating collagen fibrillogenesis and cellular maturation
por: Park, Na Rae, et al.
Publicado: (2021)

Reticulocalbin 1 is required for proliferation and migration of non‐small cell lung cancer cells regulated by osteoblast‐conditioned medium
por: Fu, Haijing, et al.
Publicado: (2021)

EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism
por: Gomez, Juliana, et al.
Publicado: (2021)

Dandelion Seed Extract Affects Tumor Progression and Enhances the Sensitivity of Cisplatin in Esophageal Squamous Cell Carcinoma
por: Li, Yuxi, et al.
Publicado: (2022)

Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance
por: Che, Yun, et al.
Publicado: (2018)

eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma
por: Liu, Ting, et al.
Publicado: (2016)

Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts
por: Martínez-Martínez, Ernesto, et al.
Publicado: (2017)

CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis
por: Tian, Tian, et al.
Publicado: (2022)

Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma
por: Song, Kewei, et al.
Publicado: (2023)

Targeting the mitochondrial calcium uniporter inhibits cancer progression and alleviates cisplatin resistance in esophageal squamous cell carcinoma
por: Miao, Yu, et al.
Publicado: (2023)

Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin
por: Aune Westergaard Hansen, Gry, et al.
Publicado: (2015)

CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer
por: Wang, Jiansong, et al.
Publicado: (2019)

TAOK3 Facilitates Esophageal Squamous Cell Carcinoma Progression and Cisplatin Resistance Through Augmenting Autophagy Mediated by IRGM
por: Sun, Mingchuang, et al.
Publicado: (2023)

Correction: Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin
por: Aune Westergaard Hansen, Gry, et al.
Publicado: (2015)

Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma
por: Chen, Qiuyu, et al.
Publicado: (2023)

Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma
por: Shi, Yan, et al.
Publicado: (2013)

Overexpression of PRR11 promotes tumorigenic capability and is associated with progression in esophageal squamous cell carcinoma
por: Zhou, Li, et al.
Publicado: (2019)

RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes
por: Zeng, Rui‐Jie, et al.
Publicado: (2019)

Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling
por: Cui, Wei, et al.
Publicado: (2020)

Progressive decay of Ca(2+) homeostasis in the development of diabetic cardiomyopathy
por: Zhao, Shu-Mei, et al.
Publicado: (2014)

TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma
por: Xu, Fengkai, et al.
Publicado: (2019)

Association between circ_0004365 and cisplatin resistance in esophageal squamous cell carcinoma
por: Yamada, Moyuru, et al.
Publicado: (2023)

LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma
por: Tao, Mingyue, et al.
Publicado: (2021)

Down-Regulation of CIDEA Promoted Tumor Growth and Contributed to Cisplatin Resistance by Regulating the JNK-p21/Bad Signaling Pathways in Esophageal Squamous Cell Carcinoma
por: Gao, Ya-Ping, et al.
Publicado: (2021)

Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma
por: Zhang, Liangze, et al.
Publicado: (2017)

Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
por: Wang, Xin, et al.
Publicado: (2023)

CD73 Promotes Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2021)

Promoting role of pentraxin-3 in esophageal squamous cell carcinoma
por: Fan, Zhirui, et al.
Publicado: (2022)

SHCBP1 Promotes the Progression of Esophageal Squamous Cell Carcinoma Via the TGFβ Pathway
por: Ren, Chunhong, et al.
Publicado: (2021)

MTHFD1L-Mediated Redox Homeostasis Promotes Tumor Progression in Tongue Squamous Cell Carcinoma
por: Li, Hao, et al.
Publicado: (2019)

Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9
por: Wang, Lianghai, et al.
Publicado: (2017)

Chaperone‐mediated autophagy affects tumor cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma
por: Cao, Dujuan, et al.
Publicado: (2021)

Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer
por: Liu, Xuejiao, et al.
Publicado: (2023)

Cisplatin attenuates taste cell homeostasis and induces inflammatory activation in the circumvallate papilla
por: Ren, Wenwen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d8m6gnn9hmka7ms2qn15q4pt71